FIELD: biotechnology.
SUBSTANCE: inventions relate to a method for regulating the immune system of a subject, comprising of administering to the subject of a composition including a bacterial species of Roseburia hominis; a method of treating a disorder in a subject, including administration to the subject of a composition comprising of Roseburia hominis; a pharmaceutical composition comprising of Roseburia hominis, and a method of producing such a composition. The composition, used for the regulation of the immune system of a mammal and/or treatment of disorders in mammals, includes Roseburia hominis in a quantity from about 1×106 to about 1×1011 colony forming units/g relative to weight of the composition or daily dose of Roseburia hominis is approximately from 1×103 to about 1×1011 colony-forming units.
EFFECT: inventions allow modulating metabolic activity in the digestive tract and can be used in immunoregulatory processes.
6 cl, 15 dwg
Title | Year | Author | Number |
---|---|---|---|
BACTERIUM FOR USE AS PROBIOTIC CONSUMED WITH FOOD AND IN MEDICINE | 2012 |
|
RU2761636C2 |
POLYPEPTIDE AND IMMUNE MODULATION | 2014 |
|
RU2682651C2 |
USE OF MICROBIAL COMMUNITIES FOR THE TREATMENT OF HUMANS AND ANIMALS | 2017 |
|
RU2758387C2 |
USE OF MICROBIAL COMMUNITIES FOR TREATING HUMANS AND ANIMALS | 2017 |
|
RU2823233C2 |
COMPOSITIONS AND METHODS | 2014 |
|
RU2664479C2 |
BACTERIAL STRAINS ISOLATED FROM PIGS | 2012 |
|
RU2677890C2 |
AGENT FOR PROPHYLAXIS AND/OR TREATMENT OF UNDESIRED INFLAMMATION ACTIVITY AND CANCER PROPHYLAXIS | 2000 |
|
RU2279282C2 |
USE OF CAROTENOID OF MICROBIAL ORIGIN THAT AFFECTS COMPOSITION OF INTESTINAL MICROORGANISMS | 2017 |
|
RU2759600C2 |
IMMUNOGENIC ANTI-INFLAMMATORY COMPOSITIONS | 2011 |
|
RU2722357C2 |
CLOSTRIDIAL TOXIN NetB | 2008 |
|
RU2474587C2 |
Authors
Dates
2018-02-21—Published
2012-10-08—Filed